| 今开：0.0 | 昨收：0.89 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.3222298E7 |
chuminhua2019-10-02 17:00
$Newlink Genetics(NLNK)$ 10/1，3年前，NewLink Genetics的IDO药物被寄予厚望，该公司股价曾超过每股50元，现在希望破灭，该公司股价仅为1.59美元，市值缩水至5900万美元，创始人Charles Link几个月前离职。现在该公司宣布合并，与投资人50/50，明年初合并完成后，公司将更名为Lumos，并以$LUMO代...查看全文
chuminhua2019-09-18 22:46
$Newlink Genetics(NLNK)$ NewLink 公司9月17日宣布，FDA已经受理默沙东(MSD)埃博拉疫苗V920的新药上市申请（BLA），用于预防埃博拉病感染相关疾病。FDA同时授予V920优先审评资格，预定审批期限是2020/3/14。014年底，当非洲西部埃博拉疫情达到高峰时，默沙东从NewLink公司签署了一项全球独家授权...查看全文
东莱千户2019-03-31 15:33
$Newlink Genetics(NLNK)$
Background: NLG207 (formerly CRLX101) is an investigational nanoparticle-drug conjugate (NDC) composed of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase-1 inhibitor. NDCs enhance drug delivery to tumors where gradua...查看全文
一年交易一次2018-10-19 08:05
$NewLink Genetics Corporation (NLNK)$ NewLink Genetics to Host Its Third Quarter 2018 Financial Results Conference Call on November 1, 2018 网页链接查看全文
WitnessBio2018-08-01 09:00
$NewLink Genetics Corporation (NLNK)$ Hammered by a series of setbacks, NewLink axes staff (again) and circles its wagons around troubled IDO program.
Endpoints查看全文
$Newlink Genetics(NLNK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-06 AccNo: 0001126234-19-000142 Size: 5 MB 网页链接
$Newlink Genetics(NLNK)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-10-01 AccNo: 0001126234-19-000133 Size: 80 KB 网页链接
$Newlink Genetics(NLNK)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-09-30 AccNo: 0001126234-19-000131 Size: 5 MB 网页链接
$Newlink Genetics(NLNK)$ 8-K - Current report Filed: 2019-09-30 AccNo: 0001126234-19-000130 Size: 5 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 3.02: Unregistered Sales of Equity SecuritiesItem 3.03: M...
$Newlink Genetics(NLNK)$ 8-K - Current report Filed: 2019-09-17 AccNo: 0001126234-19-000124 Size: 54 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Newlink Genetics(NLNK)$ SC TO-I/A [Amend] - Tender offer statement by Issuer Filed: 2019-08-29 AccNo: 0001126234-19-000122 Size: 29 KB 网页链接
$Newlink Genetics(NLNK)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-08 AccNo: 0001126234-19-000115 Size: 5 MB 网页链接
$Newlink Genetics(NLNK)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001126234-19-000086 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Newlink Genetics(NLNK)$ 8-K - Current report Filed: 2019-07-30 AccNo: 0001126234-19-000084 Size: 185 KBItem 2.02: Results of Operations and Financial ConditionItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compe...
$Newlink Genetics(NLNK)$ EFFECT - Notice of Effectiveness Filed: 2019-07-22 AccNo: 9999999995-19-001657 Size: 1 KB 网页链接